Chemical Hazards / Lab Safety Video Part 4

| March 25, 2015

article image
In this lesson, we'll learn about the 2 most important tools to identify chemical hazards: • Safety Data Sheets (SDS) and • Chemical Labels Many of the chemicals we use in the lab are potentially dangerous, especially under high heat, pressure, or when they're mixed with other chemicals.  (Watch all 6 lessons on YouTube: http://goo.gl/a6GT4D ) For a different take on lab safety training, check out our exciting short film, "Zombie College: The 5 Rules of Lab Safety," available now at http://youtu.be/S6WARqVdWrE.

Spotlight

Incyte

Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. Our vision is to become a leader in the development and delivery of novel drugs for serious unmet medical needs. We have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. The Incyte corporate headquarters is located in Wilmington, Delaware, and more than 625 employees comprise our experienced management.

OTHER ARTICLES

A Coordinated Approach to Chemical Reactivity

Article | March 4, 2020

Atoms are gregarious by nature, escaping a solitary existence by forming chemical bonds with their neighbors. Chemical reactivity, in turn, depends on the degree of atomic “isolation”; a lonely atom will more readily interact and form bonds with others, as compared to its more “coordinated” counterparts that are chemically engaged with other atoms. This coordination concept plays a central role in our understanding of chemical and catalytic activity. What has been lacking to date, however, is a direct and quantitative measurement of the variation in chemical reactivity of atoms having different degrees of coordination.

Read More

Petrochemicals in PA: What You Need to Know

Article | February 19, 2020

A bill recently passed by the Pennsylvania General Assembly would subsidize the use of fracked gas to produce petrochemicals. At some point—i.e., at a time chosen by the state Senate—H B 1100 will be sent to Governor Wolf, who has promised a veto despite override threats. Meanwhile, Pennsylvanians are trying to understand the bill and its potential impacts. That hasn't been easy, because as with the petrochemical subsidy bills Pennsylvania enacted in 2012, the General Assembly has not held a single hearing on the legislation. The purpose of this blog is to help fill that gap.

Read More

THE BUSINESS CASE FOR SUSTAINABILITY IN THE CHEMICAL INDUSTRY IN 2020 & BEYOND

Article | March 3, 2020

Sustainability fervor – which has been building in importance over the past few years – has reached a new height in 2020. Chemical industry leaders made lofty statements at the World Economic Forum in Davos about the importance of engaging in sustainable development. Despite that, the chemicals industry is big, conservative, and typically slow to move. This raises the question: "What factors will really force change in the chemicals industry, and what does that change look like?" In this blog, we examine three possible drivers of change – carbon taxes, investor pressure, and supply chain pressure – and discuss their possible implications. We specifically focus on chemical companies, as highly carbon-intensive industries like cement and steel face a very different picture with respect to sustainability challenges.

Read More

We need a global agreement that sets targets for reducing plastic waste

Article | May 20, 2021

What follows is an entirely personal take on the challenge of plastic waste and does not represent the views of ICIS or any other expert opinion I have sought out. The views are put forward in the spirit of debate as we move forward, as an industry, to solve the crisis of plastic waste.

Read More

Spotlight

Incyte

Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. Our vision is to become a leader in the development and delivery of novel drugs for serious unmet medical needs. We have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. The Incyte corporate headquarters is located in Wilmington, Delaware, and more than 625 employees comprise our experienced management.

Events